Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Hepion Pharmaceuticals Inc (NASDAQ: HEPA) closed the day trading at $0.02 down -39.15% from the previous closing price of $0.04. In other words, the price has decreased by -$39.15 from its previous closing price. On the day, 154.87 million shares were traded. HEPA stock price reached its highest trading level at $0.0283 during the session, while it also had its lowest trading level at $0.0213.
Ratios:
For a better understanding of HEPA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HEPA now has a Market Capitalization of 796966 and an Enterprise Value of 2581769.
Stock Price History:
The Beta on a monthly basis for HEPA is 1.72, which has changed by -0.98944956 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, HEPA has reached a high of $2.90, while it has fallen to a 52-week low of $0.04. The 50-Day Moving Average of the stock is -90.42%, while the 200-Day Moving Average is calculated to be -96.41%.
Shares Statistics:
Over the past 3-months, HEPA traded about 25.07M shares per day on average, while over the past 10 days, HEPA traded about 40772590 shares per day. A total of 10.62M shares are outstanding, with a floating share count of 10.57M. Insiders hold about 0.48% of the company’s shares, while institutions hold 14.69% stake in the company. Shares short for HEPA as of 1740700800 were 4160035 with a Short Ratio of 0.17, compared to 1738281600 on 2709108. Therefore, it implies a Short% of Shares Outstanding of 4160035 and a Short% of Float of 39.180002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
